Literature DB >> 14732692

Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.

Shaun K Olsen1, Omar A Ibrahimi, Angela Raucci, Fuming Zhang, Anna V Eliseenkova, Avner Yayon, Claudio Basilico, Robert J Linhardt, Joseph Schlessinger, Moosa Mohammadi.   

Abstract

The prototypical fibroblast growth factor receptor (FGFR) extracellular domain consists of three Ig domains (D1-D3) of which the two membrane-proximal D2 and D3 domains and the interconnecting D2-D3 linker bear the determinants of ligand binding and specificity. In contrast, D1 and the D1-D2 linker are thought to play autoinhibitory roles in FGFR regulation. Here, we report the crystal structure of the three-Ig form of FGFR3c in complex with FGF1, an FGF that binds promiscuously to each of the seven principal FGFRs. In this structure, D1 and the D1-D2 linker are completely disordered, demonstrating that these regions are dispensable for FGF binding. Real-time binding experiments using surface plasmon resonance show that relative to two-Ig form, the three-Ig form of FGFR3c exhibits lower affinity for both FGF1 and heparin. Importantly, we demonstrate that this autoinhibition is mediated by intramolecular interactions of D1 and the D1-D2 linker with the minimal FGF and heparin-binding D2-D3 region. As in the FGF1-FGFR2c structure, but not the FGF1-FGFR1c structure, the alternatively spliced betaC'-betaE loop is ordered and interacts with FGF1 in the FGF1-FGFR3c structure. However, in contrast to the FGF1-FGFR2c structure in which the betaC'-betaE loop interacts with the beta-trefoil core region of FGF1, in the FGF1-FGFR3c structure, this loop interacts extensively with the N-terminal region of FGF1, underscoring the importance of the FGF1 N terminus in conferring receptor-binding affinity and promiscuity. Importantly, comparison of the three FGF1-FGFR structures shows that the flexibility of the betaC'-betaE loop is a major determinant of ligand-binding specificity and promiscuity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732692      PMCID: PMC327120          DOI: 10.1073/pnas.0307287101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity.

Authors:  D Givol; A Yayon
Journal:  FASEB J       Date:  1992-12       Impact factor: 5.191

2.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

Review 3.  Structural and functional diversity in the FGF receptor multigene family.

Authors:  D E Johnson; L T Williams
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

4.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

5.  A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity.

Authors:  K R Dell; L T Williams
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

6.  Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms.

Authors:  J Xu; M Nakahara; J W Crabb; E Shi; Y Matuo; M Fraser; M Kan; J Hou; W L McKeehan
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

7.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.

Authors:  D M Ornitz; A Yayon; J G Flanagan; C M Svahn; E Levi; P Leder
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

8.  Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.

Authors:  F Wang; M Kan; G Yan; J Xu; W L McKeehan
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

9.  Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.

Authors:  M W Pantoliano; R A Horlick; B A Springer; D E Van Dyk; T Tobery; D R Wetmore; J D Lear; A T Nahapetian; J D Bradley; W P Sisk
Journal:  Biochemistry       Date:  1994-08-30       Impact factor: 3.162

10.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Authors:  A Yayon; Y Zimmer; G H Shen; A Avivi; Y Yarden; D Givol
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  78 in total

1.  Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.

Authors:  Govindarajan Sudha; Prashant Singh; Lakshmipuram S Swapna; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2015-09-08       Impact factor: 6.725

2.  Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.

Authors:  Laëtitia Comps-Agrar; Diana Ronai Dunshee; Dan L Eaton; Junichiro Sonoda
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

3.  Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.

Authors:  Omar A Ibrahimi; Brian K Yeh; Anna V Eliseenkova; Fuming Zhang; Shaun K Olsen; Makoto Igarashi; Stuart A Aaronson; Robert J Linhardt; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

4.  Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin.

Authors:  Nicholas J Harmer; Christopher J Robinson; Lucy E Adam; Leopold L Ilag; Carol V Robinson; John T Gallagher; Tom L Blundell
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

5.  Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.

Authors:  Shaun K Olsen; James Y H Li; Carrie Bromleigh; Anna V Eliseenkova; Omar A Ibrahimi; Zhimin Lao; Fuming Zhang; Robert J Linhardt; Alexandra L Joyner; Moosa Mohammadi
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

6.  Poly(ethylene glycol)-based biosensor chip to study heparin-protein interactions.

Authors:  Eva M Muñoz; Haining Yu; Jeannette Hallock; R Erik Edens; Robert J Linhardt
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

7.  Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.

Authors:  Xiuqin Zhang; Omar A Ibrahimi; Shaun K Olsen; Hisashi Umemori; Moosa Mohammadi; David M Ornitz
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

Review 8.  An essential role for FGF receptor signaling in lens development.

Authors:  Michael L Robinson
Journal:  Semin Cell Dev Biol       Date:  2006-10-27       Impact factor: 7.727

9.  NMR structure of the first Ig module of mouse FGFR1.

Authors:  Vladislav V Kiselyov; Elisabeth Bock; Vladimir Berezin; Flemming M Poulsen
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

Review 10.  Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.

Authors:  Edwin Li; Kalina Hristova
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.